KEVIN GIACONTIERE: Open Payments
NPI 1942205430 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 54 payments from 11 companies in 2025. Trend: 2023 $1,346 · 2024 $1,144 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 25 | $152 |
| ABBVIE INC. | 8 | $147 |
| Incyte Corporation | 5 | $121 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Lilly USA, LLC | 3 | $67 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $45 |
| Organon LLC | 3 | $40 |
| UCB, Inc. | 1 | $28 |
| Almirall LLC | 1 | $24 |
| GENZYME CORPORATION | 1 | $20 |
Products named: SKYRIZI, Opzelura, NEMLUVIO, Sotyktu, AKLIEF, TALTZ, EBGLYSS, Bimzelx.
Industry payments across TX — which companies pay providers there.
